Related references
Note: Only part of the references are listed.Nail involvement associated with palmoplantar pustulosis
Tomoko Hiraiwa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2017)
Rare association of pyoderma gangrenosum and palmoplantar pustulosis: A case report and review of the previous works
Mikio Ohtsuka et al.
JOURNAL OF DERMATOLOGY (2014)
Etiology and Management of Pyoderma Gangrenosum A Comprehensive Review
Iris Ahronowitz et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Incidence, Mortality, and Disease Associations of Pyoderma Gangrenosum in the United Kingdom: A Retrospective Cohort Study
Sinead M. Langan et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
The SAPHO Syndrome
Minhchau Thi Nguyen et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab
Emmanuella Guenova et al.
ARCHIVES OF DERMATOLOGY (2011)
Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients
A. M. Binus et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum
Masamoto Murakami et al.
EXPERIMENTAL DERMATOLOGY (2011)
Ustekinumab in the treatment of palmoplantar pustulosis
S. Gerdes et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases
A. V. Marzano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Pyoderma gangrenosum: A review and update on new therapies
Jeremiah Miller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Share Paper
